Shares of Aurora Cannabis Inc. (TSE:ACB - Get Free Report) reached a new 52-week high on Thursday . The company traded as high as C$6.74 and last traded at C$6.49, with a volume of 1819661 shares changing hands. The stock had previously closed at C$6.44.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on ACB shares. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a "hold" rating to a "buy" rating and set a C$0.80 price objective for the company in a research report on Friday, February 9th. CIBC reduced their price target on shares of Aurora Cannabis to C$6.00 and set a "neutral" rating for the company in a research report on Wednesday, February 21st. Finally, Jefferies Financial Group decreased their price target on shares of Aurora Cannabis from C$6.12 to C$4.95 and set a "hold" rating on the stock in a report on Tuesday, February 27th.
Check Out Our Latest Research Report on Aurora Cannabis
Aurora Cannabis Trading Down 7.9 %
The stock's 50 day simple moving average is C$2.75 and its 200 day simple moving average is C$1.43. The firm has a market cap of C$323.42 million, a PE ratio of -0.08 and a beta of 2.83. The company has a debt-to-equity ratio of 18.51, a quick ratio of 2.48 and a current ratio of 3.79.
Aurora Cannabis (TSE:ACB - Get Free Report) last announced its earnings results on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.10) by C($0.10). The company had revenue of C$72.61 million during the quarter, compared to analysts' expectations of C$63.50 million. Aurora Cannabis had a negative return on equity of 137.28% and a net margin of 151.71%. On average, sell-side analysts forecast that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
